These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33432476)

  • 1. Management of Difficult-to-Treat Warts: Traditional and New Approaches.
    Friedman PC
    Am J Clin Dermatol; 2021 May; 22(3):379-394. PubMed ID: 33432476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
    Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
    Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of autoimplantation therapy and intralesional injection of MMR vaccine in warts treatment.
    ElGhareeb MI
    Dermatol Ther; 2019 Nov; 32(6):e13135. PubMed ID: 31648401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts.
    Na CH; Choi H; Song SH; Kim MS; Shin BS
    Clin Exp Dermatol; 2014 Jul; 39(5):583-9. PubMed ID: 24934912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional immunotherapy of plantar warts: report of a new antigen combination.
    Gamil H; Elgharib I; Nofal A; Abd-Elaziz T
    J Am Acad Dermatol; 2010 Jul; 63(1):40-3. PubMed ID: 20462659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
    Nofal A; Nofal E; Yosef A; Nofal H
    Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature.
    Aldahan AS; Mlacker S; Shah VV; Kamath P; Alsaidan M; Samarkandy S; Nouri K
    Dermatol Ther; 2016 May; 29(3):197-207. PubMed ID: 26991521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and distal involution of recalcitrant warts after a single intralesional dose of measles, mumps, and rubella vaccine.
    Cantor AS; Hardy CL
    Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
    Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
    Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
    Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
    Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional mumps, measles and rubella vaccine in the treatment of cutaneous warts.
    Saini P; Mittal A; Gupta LK; Khare AK; Mehta S
    Indian J Dermatol Venereol Leprol; 2016; 82(3):343-5. PubMed ID: 27088951
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
    Marei A; Nofal A; Alakad R; Abdel-Hady A
    J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cutaneous warts: an evidence-based approach.
    Micali G; Dall'Oglio F; Nasca MR; Tedeschi A
    Am J Clin Dermatol; 2004; 5(5):311-7. PubMed ID: 15554732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of anogenital warts with measles, mumps, and rubella vaccine.
    Kansal NK
    Dermatol Ther; 2020 Nov; 33(6):e13987. PubMed ID: 32638481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
    Nofal A; Alakad R; Fouda I; Fawzy MM
    J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
    Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
    J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional immunotherapy for pediatric warts: A review.
    Fields JR; Saikaly SK; Schoch JJ
    Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens.
    Clifton MM; Johnson SM; Roberson PK; Kincannon J; Horn TD
    Pediatr Dermatol; 2003; 20(3):268-71. PubMed ID: 12787281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of intralesional wart therapy.
    Muse ME; Stiff KM; Glines KR; Cline A; Feldman SR
    Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.
    Johnson SM; Roberson PK; Horn TD
    Arch Dermatol; 2001 Apr; 137(4):451-5. PubMed ID: 11295925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.